|
ADIPOR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.359220E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.551800E-01 |
| Normal-vs-Stage2 |
4.779400E-01 |
| Normal-vs-Stage3 |
1.019640E-04 |
| Normal-vs-Stage4 |
1.529790E-01 |
| Stage1-vs-Stage2 |
3.623200E-01 |
| Stage1-vs-Stage3 |
4.17040000000313E-05 |
| Stage1-vs-Stage4 |
2.647200E-01 |
| Stage2-vs-Stage3 |
3.631900E-02 |
| Stage2-vs-Stage4 |
1.845380E-01 |
| Stage3-vs-Stage4 |
1.199230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.991630E-01 |
| Normal-vs-AfricanAmerican |
5.187700E-02 |
| Normal-vs-Asian |
7.925600E-01 |
| Caucasian-vs-AfricanAmerican |
2.368400E-01 |
| Caucasian-vs-Asian |
8.903400E-01 |
| AfricanAmerican-vs-Asian |
5.173800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.966030E-01 |
| Normal-vs-Female |
1.769810E-01 |
| Male-vs-Female |
9.180600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.517800E-02 |
| Normal-vs-Age(41-60Yrs) |
9.831400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.236270E-02 |
| Normal-vs-Age(81-100Yrs) |
2.702000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.270810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.310200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.938400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.403500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.300300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.009800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.568600E-01 |
| Normal-vs-Grade 2 |
5.688600E-01 |
| Normal-vs-Grade 3 |
1.999200E-03 |
| Normal-vs-Grade 4 |
5.994000E-02 |
| Grade 1-vs-Grade 2 |
2.035200E-01 |
| Grade 1-vs-Grade 3 |
6.894300E-02 |
| Grade 1-vs-Grade 4 |
3.200300E-02 |
| Grade 2-vs-Grade 3 |
4.436600E-03 |
| Grade 2-vs-Grade 4 |
8.853800E-02 |
| Grade 3-vs-Grade 4 |
9.053400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.145000E-01 |
| Normal-vs-ccB subtype |
4.654800E-01 |
| ccA subtype-vs-ccB subtype |
8.604200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.169800E-01 |
| Normal-vs-N1 |
2.707800E-01 |
| N0-vs-N1 |
5.666000E-01 |
|
|
